Borja E. Sanz-Cuesta, Jeffrey L. Saver:Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors.Stroke,2021-10, 52. vsk, nro 10, s. 3142–3150.doi:10.1161/STROKEAHA.121.034576ISSN0039-2499Artikkelin verkkoversio.(englanniksi)
Collins, Rory ym.:Interpretation of the evidence for the efficacy and safety of statin therapy.The Lancet,2016-11, 388. vsk, nro 10059, s. 2532–2561.doi:10.1016/S0140-6736(16)31357-5Artikkelin verkkoversio.Viitattu 19.7.2026.(englanniksi)
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain:Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.Journal of the American College of Cardiology,19.8.2008, nro 8, s. 626–632.PubMed:18702965doi:10.1016/j.jacc.2008.04.052ISSN1558-3597Artikkelin verkkoversio.
Borja E. Sanz-Cuesta, Jeffrey L. Saver:Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors.Stroke,2021-10, 52. vsk, nro 10, s. 3142–3150.doi:10.1161/STROKEAHA.121.034576ISSN0039-2499Artikkelin verkkoversio.(englanniksi)
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi:Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.PLOS ONE,7.1.2015, nro 10, s. e0124451.PubMed:26132393doi:10.1371/journal.pone.0124451ISSN1932-6203Artikkelin verkkoversio.(englanniksi)
DyslipidemiatKäypä Hoito -suositus.14.12.2022.Suomalaisen Lääkäriseuran Duodecimin ja Suomen Sisätautilääkärien Yhdistys ry:n asettama työryhmä. Viitattu 18.7.2026.
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain:Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.Journal of the American College of Cardiology,19.8.2008, nro 8, s. 626–632.PubMed:18702965doi:10.1016/j.jacc.2008.04.052ISSN1558-3597Artikkelin verkkoversio.
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi:Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.PLOS ONE,7.1.2015, nro 10, s. e0124451.PubMed:26132393doi:10.1371/journal.pone.0124451ISSN1932-6203Artikkelin verkkoversio.(englanniksi)
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi:Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.PLOS ONE,7.1.2015, nro 10, s. e0124451.PubMed:26132393doi:10.1371/journal.pone.0124451ISSN1932-6203Artikkelin verkkoversio.(englanniksi)
Collins, Rory ym.:Interpretation of the evidence for the efficacy and safety of statin therapy.The Lancet,2016-11, 388. vsk, nro 10059, s. 2532–2561.doi:10.1016/S0140-6736(16)31357-5Artikkelin verkkoversio.Viitattu 19.7.2026.(englanniksi)
Christie M. Ballantyne, Joel S. Raichlen, Valerie A. Cain:Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.Journal of the American College of Cardiology,19.8.2008, nro 8, s. 626–632.PubMed:18702965doi:10.1016/j.jacc.2008.04.052ISSN1558-3597Artikkelin verkkoversio.
Borja E. Sanz-Cuesta, Jeffrey L. Saver:Lipid-Lowering Therapy and Hemorrhagic Stroke Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors.Stroke,2021-10, 52. vsk, nro 10, s. 3142–3150.doi:10.1161/STROKEAHA.121.034576ISSN0039-2499Artikkelin verkkoversio.(englanniksi)
Beatrice A. Golomb, Joel E. Dimsdale, Hayley J. Koslik, Marcella A. Evans, Xun Lu, Steven Rossi:Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.PLOS ONE,7.1.2015, nro 10, s. e0124451.PubMed:26132393doi:10.1371/journal.pone.0124451ISSN1932-6203Artikkelin verkkoversio.(englanniksi)